RxDoctor Payments Data

Jamie Fields, APRN

Family · Liberty Twp, OHNPI 1235794439

Payments from drug & device makers

$1,358in general payments, 2019–2025

Across 70 payments — averaging $19.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$253
  • AbbVie$246
  • AstraZeneca$202
  • Novo Nordisk$183
  • Exact Sciences$95
  • GSK$70
  • plus $309 from 13 others

What the payments were for

  • Food & beverage$1,358100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,358 in reported general payments places this provider in the 75th percentile of 6,812 family providers in Ohio.

See all family providers in Ohio

Medicare billing

Part B allowed, 2024
$9,825
Medicare patients
52
Services billed
139

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide11$13,025
TrulicityDulaglutide12$12,812
Combivent RespimatIpratropium/Albuterol Sulfate14$6,581
SymbicortBudesonide/Formoterol Fumarate22$5,192
Humalog Kwikpen U-100Insulin Lispro11$1,087
Lantus SolostarInsulin Glargine,hum.Rec.Anlog12$979
Albuterol Sulfate HfaAlbuterol Sulfate19$784
Gabapentin33$756
Oxybutynin Chloride ErOxybutynin Chloride12$438
Pravastatin Sodium31$324
Rosuvastatin Calcium19$313
Levothyroxine Sodium29$280
Atorvastatin Calcium52$277
Metformin Hcl ErMetformin Hcl21$236
Fluticasone Propionate13$230

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$253$25,83823 claims
AstraZenecaSymbicort$202$5,19222 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 6,812 family providers in Ohio.

Other family in Liberty Twp

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →